TGFB1 and pulmonary fibrosis: The PAI1 inhibitor SK-216 blocks TGFβ-induced EMT, including PAI1 neosynthesis, fibroblast to myofibroblast terminal differentiation and bleomycin-induced lung fibrosis [216].